CC-90009, a novel CELMoD, emerged as the first MG from BMS’s library via phenotypic screening.486 In preclinical studies, it selectively degraded GSPT1, exhibiting strong anti-proliferative effects in AML cell lines and patient-derived cells. The gene discussed is GSPT1; the disease is acute myeloid leukemia.